CoChat

Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial

Lagarde, William H., Barrows, Frank P., Davenport, Marsha L., Kang, Minsun, Guess, Harry A., Calikoglu, Ali S. · 2006 · Pediatric Diabetes
Cited by 72

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Tight glycemic control delays the long-term complications of type 1 diabetes mellitus (T1DM) but increases the risk for hypoglycemia. The continuous glucose-monitoring system (CGMS) provides blood glucose (BG) readings every 5 min, and its accuracy and reliability has been established in adults. However, there are limited data on its efficacy and safety in children. The purpose of this study was to determine if CGMS use improves metabolic control in children with T1DM. METHODS: Twenty-seven children (12 male) with T1DM participated in this single-blind, randomized, controlled trial. Participants (age: 11.4 +/- 3.7 (mean +/- SD) yr, range: 7-17 yr) were randomized to an intervention group (n = 18) or a control group (n = 9). Both groups wore the CGMS for 72-h periods at 0, 2, and 4 months. Adjustments in therapy for the intervention group were based on both CGMS and self-monitoring of BG (SMBG) data, while only SMBG data were used for the control group. Hemoglobin A1c (HbA1c) was determined at 0, 2, 4, and 6 months. The change in HbA1c from 0 to 6 months (HbA1c(Delta1-4)) and mean daily area under the CGMS curve for glucose <70 mg/dL area under the curve (AUC(<70)) were compared between groups. RESULTS: At study entry, HbA1c levels were similar in the intervention and control groups (8.4 +/- 0.98 and 8.8 +/- 0.86%, respectively; p = 0.12) but were significantly lower in the intervention group compared with the control group at study completion (7.8 +/- 0.88 and 8.6 +/- 0.95%, respectively; p = 0.02). The decrease in HbA1c of 0.61 +/- 0.68% in the intervention group was statistically significant (p = 0.03), whereas the decrease in HbA1c of 0.28 +/- 0.78% in the control group was not. Nonetheless, the differences in HbA1c(Delta1-4) between groups did not reach statistical significance (p = 0.13). There was no statistically significant difference in AUC(<70) between study groups (p = 0.18). CONCLUSION: CGMS use may improve metabolic control in children with T1DM without increasing the risk for hypoglycemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1399-543x.2006.00162.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 16

  1. 10.1056/NEJM199309303291401 · DOI · Paper page
  2. 10.1111/j.1399-543X.2004.00045.x · DOI · Paper page
  3. 10.1017/S1355617703950077 · DOI · Paper page
  4. 10.1017/S0012162203000501 · doi:10.1017/s0012162203000501 · Paper page
  5. McCarthy AM, 2003, Diabetes Care, 26, 112, 10.2337/diacare.26.1.112 · DOI · Paper page
  6. Hershey T, 1999, Diabetes Care, 22, 1318, 10.2337/diacare.22.8.1318 · DOI · Paper page
  7. Monsod TP, 2002, Diabetes Care, 25, 889, 10.2337/diacare.25.5.889 · DOI · Paper page
  8. 10.1046/j.1464-5491.2003.01037.x · DOI · Paper page
  9. 10.1046/j.1464-5491.2003.00837.x · DOI · Paper page
  10. 10.1089/152091503765691866 · DOI
  11. 10.1089/dia.2005.7.109 · DOI · Paper page
  12. 10.1542/peds.107.2.222 · DOI · Paper page
  13. 10.1542/peds.111.5.933 · DOI · Paper page
  14. Schaepelynck-Belicar P, 2003, Diabetes Metab, 29, 608, 10.1016/S1262-3636(07)70076-9 · DOI
  15. 10.1001/archpedi.158.7.677 · DOI · Paper page
  16. 10.1089/152091503322526987 · DOI · Paper page

Cited by

See all 72

Metadata

Authors
Lagarde, W. H., Barrows, F. P., Davenport, M. L., Kang, M., Guess, H. A., & Calikoglu, A. S.
Venue
Pediatric Diabetes
Published
2006-06
Volume
7
Issue
3
Pages
159-164
ISSN
  • 1399-543X (ISSN-L)
  • 1399-5448
OpenAlex
W2155678748
Cited by
72
References
2
FWCI
5.65
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 3379 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.